polycaprolactone (PCL), SF solution, BMP-2 |
In vivo |
Electric field |
As an effective carrier of BMP-2 for functional repair of large bone defects |
[123] |
SF solution, BMP-2, VEGF-165 |
In vitro and in vivo |
Ultrasonication |
Promote repair of irregular bone cavity defects |
[124] |
SF, PEG, PLA/PLGA, BMP-2 |
In vitro and in vivo |
Self-assembly |
Maintains protein bioactivity and prolongs degradation |
[11] |
SF, HA, DA |
In vitro |
Ultrasonication |
Used as tissue engineering scaffold material for bone regeneration |
[131] |
CHA/SF/GCS/DF-PEG hydrogels |
In vitro and in vivo |
Self-assembly |
Facilitates bone collagen deposition and maturation |
[132] |
SF, GO, nHA, BMP-2 |
In vitro and in vivo |
Click-chemistry cross-linking |
Repair of bone defects |
[133] |
HAP, SF |
In vitro |
γ-Ray irradiation |
Enhanced osteogenic differentiation of hMSCs in vitro |
[36] |
SF, MSM-10 |
In vitro and in vivo |
Ultrasonication |
Improving in vitro osteogenic properties of hydrogels |
[139] |
RSF, LAP |
In vitro and in vivo |
Ultrasonication |
Mediates activation of AKT signaling pathway in BMSCs |
[140] |
SF solution, HRP, H2O2, SiNPs |
In vitro and in vivo |
Enzyme cross-linking. |
Bone regeneration without any exogenous MSCs or growth factors |
[143] |